Get started
Author

Elke Berg

OpenAlex ID: A5000676414
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
2020 · Viktoria F. Koehler, Pia Adam, et al. · Thyroid · 68
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
2021 · Pia Adam, Stefan Kircher, et al. · Frontiers in Endocrinology · 43
PDF
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer
2021 · Viktoria Florentine Koehler, Elke Berg, et al. · Thyroid · 40
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis
2022 · Viktoria Florentine Koehler, Pia Adam, et al. · Cancers · 9
PDF
Impact of genomic biomarkers on treatment decisions and clinical outcomes in patients with radioiodine-refractory thyroid cancer and treatment with multi-tyrosine kinase inhibitors - a multi-center registry analysis
2024 · Josefine Achterfeld, Viktoria Kohler, et al. · Endocrine Abstracts
Works count: 5
Citation count: 160
H-index: 4
I10-index: 3
Year
Topic
Type